期刊文献+

靶控输注丙泊酚复合瑞芬太尼全静脉麻醉在腹腔镜手术中的应用 被引量:6

暂未订购
导出
摘要 目的:探讨靶控输注丙泊酚复合瑞芬太尼全静脉麻醉在腹腔镜手术中的安全性和可靠性。方法:回顾性分析近半年笔者所在医院靶控输注丙泊酚复合瑞芬太尼全静脉麻醉腹腔镜手术83例的临床资料,观察TCI时间、自主呼吸恢复时间、呼唤患者睁眼时间、拔管时间,记录插管前后BP、HR及术中心血管事件及用药情况;术后询问术中知晓情况。结果:所有患者顺利完成手术,TCI输注时间47~163min,停药至睁眼时间5~14min,停药至拔管时间7~18min,诱导时所有患者血压均出现下降,插管时血压、心率波动轻微,无明显血流动力学反应,术中麻醉经过平稳,停止输注后患者很快睁眼并拔管,且苏醒完全,无苏醒延迟病例发生,苏醒期无明显躁动病例发生,无术中知晓病例发生。结论:靶控输注丙泊酚复合瑞芬太尼全静脉麻醉可安全有效地应用于腹腔镜手术的麻醉。
机构地区 大理州中医医院
出处 《中外医学研究》 2013年第10期102-103,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献9

  • 1Troy A M, Huthinson R C, Kenny G N C, et al.Treacheal intubating conditions using proprfol and remifentanil infudions[J].Anaesthesia, 2002, 98(3): 1204-1207.
  • 2Grankshaw D P, Chan C, Leslie K, et al.Remifentanil concentration during target-controlled infusion propofol[J].Anesth Intensive Care, 2002, 30(2): 578-583.
  • 3Minto C F, Schnider T W, Egan T D, et al.Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil.[J] I.Model development.Anesthesiology, 1997, 93(4): 10-23.
  • 4Schuttler J, Ihmsen H.Population pharmacokinetics of propofol: a muhicenterstudy[J].Anesthesiology, 2000, 96(1): 727-738.
  • 5余守章,主编.微创手术麻醉学[M].北京:人民卫生出版社,2008:19-22.
  • 6Mertens M J, Olofsen E, Engbers F I-I, et al.Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions[J]. Anesthesiology, 2003, 99(2): 347-349.
  • 7耿志宇,许幸,吴新民.瑞芬太尼复合异丙酚靶控输注诱导时的量效关系[J].中华麻醉学杂志,2004,24(4):260-263. 被引量:181
  • 8张熙哲,吴新民.异丙酚靶控输注时瑞芬太尼抑制气管插管反应的半数有效血浆浓度[J].中华麻醉学杂志,2006,26(3):204-206. 被引量:46
  • 9孙吉锋.瑞芬太尼复合异丙酚静脉麻醉在开胸手术中的应用[J].中国实用医药,2009,4(2):169-169. 被引量:5

二级参考文献21

  • 1史春霞,李立环,卿恩明,姜贞,李士通,姚尚龙,郭曲练,王文贤,熊利泽,张铁铮,齐娟,付志俭.舒芬太尼麻醉用于心血管手术的多中心临床研究[J].临床麻醉学杂志,2005,21(8):519-521. 被引量:114
  • 2薛昀,吴新民.靶控输注瑞芬太尼或芬太尼对术前病人异丙酚镇静作用的影响[J].中华麻醉学杂志,2005,25(10):729-732. 被引量:21
  • 3Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999, 89(4 Suppl):S7-14.
  • 4Vuyk J, Mertens M J, Olofsen E, et al. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC90 propofal-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology, 1997, 87: 1549
  • 5Vuyk J, Engbers FH, Burm AG, et al. Pharmacodynamic interaction between propofol and alfentanil when given for induction of anesthesia.Anesthesiology, 1996, 84: 288-299.
  • 6Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision.Anesthesiology, 1994, 81: 820-828.
  • 7V uyk J, Engbers FH, Lemmens HJ, et al. Pharmacodynamics of propofol in female patients. Anesthesiology, 1992, 77: 3-9.
  • 8Vuyk J, Lim T, Engber FH, et al. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women.Anesthesiology, 1995, 83: 8-22.
  • 9Thompson JP, Hall AP, Russell J, et al. Effect of remifentanil on the haemodynamic response to orotracheal intubation. Br J Anaesth, 1998,80: 467-469.
  • 10Schuttler J, Albrecht S, Breivik H, et al. A comparison of remifcntanil and alfcntanil in patients undergoing major abdominal surgery.Anaesthesia, 1997,52: 307-317.

共引文献227

同被引文献46

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部